Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors for the treatment of non-small cell lung cancer: a patent review (2014-present)
2017 ◽
Vol 80
(6)
◽
pp. 1179-1187
◽
2014 ◽
Vol 32
(6)
◽
pp. 1311-1315
◽